2015
Lymphadenopathy/lymphadenitis
Shenoi S, Friedland G. Lymphadenopathy/lymphadenitis. 2015, 184-191. DOI: 10.1017/cbo9781139855952.033.Peer-Reviewed Original Research
2010
Blood cultures for the diagnosis of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected patients from rural South Africa: a cross-sectional study
Heysell SK, Thomas TA, Gandhi NR, Moll AP, Eksteen FJ, Coovadia Y, Roux L, Babaria P, Lalloo U, Friedland G, Shah S. Blood cultures for the diagnosis of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected patients from rural South Africa: a cross-sectional study. BMC Infectious Diseases 2010, 10: 344. PMID: 21134279, PMCID: PMC3016377, DOI: 10.1186/1471-2334-10-344.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAIDS-Related Opportunistic InfectionsChildChild, PreschoolCross-Sectional StudiesExtensively Drug-Resistant TuberculosisFemaleHIV InfectionsHumansInfantInfant, NewbornMaleMiddle AgedMycobacterium tuberculosisRetrospective StudiesRisk FactorsRural PopulationSouth AfricaSputumYoung AdultConceptsDrug-resistant TBMycobacterial blood culturesDrug-resistant tuberculosisBlood culturesXDR-TBRural South AfricaMDR-TBM. tuberculosisMycobacterium tuberculosis bacteremiaCross-sectional studyPositive blood culturesDiagnosis of MDRCross-sectional analysisAntiretroviral therapySecondary outcomesSputum cultureTB suspectsRisk factorsPatientsHIVTuberculosisDiagnosisTBSimilar settingsBacteremiaRapid Diagnosis Of Tuberculosis And MDR TB Using The Microscopic-Observation Drug-Susceptibility (MODS) Assay In A High HIV Prevalence Setting – South Africa
Shah S, Babaria P, Moodley P, Heysell S, Sturm W, Moll A, Mhlongo P, Moodley S, Ramtahal M, Richardson J, Li X, Friedland G, Gandhi N. Rapid Diagnosis Of Tuberculosis And MDR TB Using The Microscopic-Observation Drug-Susceptibility (MODS) Assay In A High HIV Prevalence Setting – South Africa. 2010, a2256-a2256. DOI: 10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a2256.Peer-Reviewed Original Research
2007
Tuberculosis, drug resistance, and HIV/AIDS: A triple threat
Friedland G. Tuberculosis, drug resistance, and HIV/AIDS: A triple threat. Current Infectious Disease Reports 2007, 9: 252. PMID: 17430708, DOI: 10.1007/s11908-007-0039-7.Peer-Reviewed Original ResearchTB drug resistanceHIV/AIDSDrug-resistant tuberculosisDrug resistanceTB control programsRapid molecular diagnostic techniquesMultiple drug resistanceAvailable diagnostic technologiesMolecular diagnostic techniquesTB diagnosisWorldwide epidemicTreatment successTherapeutic strategiesTuberculosisTherapeutic agentsAIDSThird epidemicTreatmentDiagnosisDiagnostic techniquesControl programsDiagnostic technologiesEpidemicTriple threatUrgent need
1996
Use of a quantitative cytomegalovirus (CMV) antigenemia test in evaluating HIV+ patients with and without CMV disease.
Wetherill PE, Landry ML, Alcabes P, Friedland G. Use of a quantitative cytomegalovirus (CMV) antigenemia test in evaluating HIV+ patients with and without CMV disease. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1996, 12: 33-7. PMID: 8624758, DOI: 10.1097/00042560-199605010-00005.Peer-Reviewed Original ResearchMeSH KeywordsAdultAIDS-Related Opportunistic InfectionsAntibodies, MonoclonalAntigens, ViralCross-Sectional StudiesCytomegalovirusCytomegalovirus InfectionsCytomegalovirus RetinitisFemaleFluorescent Antibody TechniqueHIV SeropositivityHIV-1HumansLeukocytesMaleMiddle AgedPredictive Value of TestsRetrospective StudiesViral Matrix ProteinsViremiaConceptsCMV antigenemia testCMV diseaseAntigenemia testCMV antigenemiaHIV diseaseCytomegalovirus antigenemia testPositive CMV antigenemiaLife-threatening infectionsDiagnostic techniquesAntigenemia levelsAntigenemia resultsCMV retinitisCytomegalovirus infectionCMV cultureClinical evidenceOphthalmologic examPatientsDiseaseRapid diagnosisAntigenemiaInfectionDiagnosisQuantitative diagnostic techniqueRetinitisHIV
1991
Survival differences in patients with AIDS.
Friedland G, Saltzman B, Vileno J, Freeman K, Schrager L, Klein R. Survival differences in patients with AIDS. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1991, 4: 144-53. PMID: 1987352.Peer-Reviewed Original ResearchConceptsPneumocystis carinii pneumoniaFavorable survivalCarinii pneumoniaMale sexYounger ageRisk behaviorsInitial AIDS diagnosisSingle medical centerIntravenous drug usePoint of diagnosisInitial AIDSMedian survivalAIDS diagnosisBlack raceSurvival differencesKaposi's sarcomaMedical CenterClinical carePatientsDrug useAIDSSurvivalDiagnosisPowerful predictorMonths
1987
Inability to predict diagnosis in febrile intravenous drug abusers.
Marantz P, Linzer M, Feiner C, Feinstein S, Kozin A, Friedland G. Inability to predict diagnosis in febrile intravenous drug abusers. Annals Of Internal Medicine 1987, 106: 823-8. PMID: 3579068, DOI: 10.7326/0003-4819-106-6-823.Peer-Reviewed Original ResearchConceptsIntravenous drug abusersFinal diagnosisEmergency roomTrivial illnessDrug abusersDistribution of diseaseInfective endocarditisConsecutive admissionsPhysicians' predictionsClinical dataDiagnostic predictionClinical informationPredictive valuePatientsDiagnosisIllnessLaboratory dataEndocarditisAbusersHospitalizationPneumoniaAdmissionFeverDisease
1978
Management Strategies for Urinary and Vaginal Infections
Komaroff A, Pass T, McCue J, Cohen A, Hendricks T, Friedland G. Management Strategies for Urinary and Vaginal Infections. JAMA Internal Medicine 1978, 138: 1069-1073. PMID: 666465, DOI: 10.1001/archinte.1978.03630320013008.Peer-Reviewed Original ResearchConceptsVaginal infectionsEfficient clinical strategyPrimary care clinicsDiagnosis of UTIDiagnosis of vaginitisCare clinicsUrine culturePhysical examinationUrinary tractPelvic examinationClinical dataExclusive diagnosisPossible diagnosisUTIClinical strategiesDetailed historyPatientsVaginitisDiagnosisUrinalysisTwo-year periodInfectionExaminationDysuriaUrinary